REGENXBIO (NASDAQ:RGNX)

CAPS Rating: 4 out of 5

Caps

How do you think RGNX will perform against the market?

Add Stock to CAPS Watchlist

All Players

25 Outperform
1 Underperform
 

All-Star Players

8 Outperform
1 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top RGNX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

RGNX VS S&P 500 (SPY)

RGNX Summary

Fools bullish on RGNX are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about RGNX.

Recs

0
Member Avatar meridius91 (67.60) Submitted: 9/27/2018 12:08:01 PM : Outperform Start Price: $76.70 RGNX Score: -10.48

Love the optionality of partners and internal pipeline combined with a differentiated competitive advantage.

Recs

0
Member Avatar Bigsef77 (69.13) Submitted: 9/14/2018 12:47:00 PM : Outperform Start Price: $77.85 RGNX Score: -15.87

Regenxbio (RGNX) has risen 121.35% YTD (year-to-date). Wall Street analysts expect it to report revenues of $194.55 million in 2018, which is a YoY (year-over-year) rise of 1,772.47%. Regenxbio expects license revenues in the second half of 2018 to be much lower than the first half of 2018 due to the non-recurring nature of those revenues.

Recs

0
Member Avatar TMFEBCapital (59.99) Submitted: 7/12/2018 12:41:22 PM : Outperform Start Price: $74.85 RGNX Score: -12.74

Big risk, big reward. Data from phase 1 trials in wet AMD and HoFH are on tap later this year. Solid balance sheet helped by $100 million payment in June from Novartis tied to NVS acquisition of AveXis, which is developing AVXS-101, an SMA gene therapy using RGNX's viral vectors.

Leaderboard

Find the members with the highest scoring picks in RGNX.

Score Leader

otherAquanaut

otherAquanaut (99.77) Score: +532.10

The Score Leader is the player with the highest score across all their picks in RGNX.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
otherAquanaut 99.77 3/30/2016 9/26/2018 Outperform 3M $9.61 +564.62% +32.52% +532.10 0 Comment
portefeuille 98.39 3/24/2016 Outperform 5Y $9.85 +548.43% +34.96% +513.47 0 Comment
portefeuille2 99.13 9/12/2016 Outperform 5Y $12.82 +398.21% +28.72% +369.49 0 Comment
clangmead 38.52 9/12/2016 Outperform 5Y $12.82 +398.21% +28.72% +369.49 1 Comment
efarev 98.66 5/23/2017 Outperform 5Y $18.60 +243.39% +13.90% +229.49 0 Comment
SaintCroix 98.58 1/22/2018 Outperform 5Y $27.15 +135.25% -2.98% +138.23 0 Comment
PoolSkunk 74.13 3/28/2018 Outperform 5Y $29.15 +119.11% +4.94% +114.17 0 Comment
hyperionives 78.36 9/26/2017 Outperform 5Y $30.65 +108.38% +9.64% +98.74 0 Comment
jeepdrew222 56.40 12/22/2017 Outperform 5Y $32.95 +93.84% +2.33% +91.51 0 Comment
tortuga94 69.00 10/4/2017 Outperform 5Y $32.10 +98.97% +8.19% +90.78 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for RGNX.

Advertisement